Parikshit Padhi M.D., M.B.B.S.
Parikshit Padhi
M.D., M.B.B.S.
Clinical Assistant Professor
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Cancer Chemotherapy; Combination Chemotherapy; Hematology; Hemostasis / Thrombosis; Immune Checkpoint Inhibitors; Internal Medicine; Medical Oncology; Oncology
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDProfessional Summary:
I am a medical hematologist and oncologist and provide comprehensive care towards patients with blood disorders and cancers. My interest lie in malignant hematology, breast cancers, melanomas and genitourinary cancers. I provide chemotherapy, immunotherapy and targeted therapy. My focus is ensuring that patients are provided with the best possible treatment and are treated with the utmost compassion. I believe in clinical research and I have been involved in multiple pharmaceutical and co-operative group trials.
I work in a multidisciplinary approach, as I believe that is the best way to treat cancers. This includes surgeons, radiation oncologists, radiologists, pathologists and other subspecialties. This ensures that all patients are provided with the best care.
I enjoy teaching students, residents and fellows. I mentor UB medical students, UB internal medicine residents, UB family medicine residents and hematology/oncology fellows. In my field along with teaching the fundamentals of blood disorders and management of cancers, I believe in teaching compassion and how to deal with difficult circumstances. My belief is if you can make a cancer patient smile and comfortable, then they are halfway there in their treatment journey and I instill that in future doctors and hematologists/oncologists.
Education and Training:
- MD, Hematology and Oncology, Allegheny Health Network (2017)
- MD, Internal Medicine, Allegheny Health Network (2014)
- M.B.B.S., Kasturba Medical College, Manipal (2010)
Employment:
- Clinical Assistant Professor, Internal Medicine-Hematology and Oncology, Jacobs School of Medical and Biomedical Sciences, University at Buffalo (2022-present)
- Adjunct Faculty, Internal Medicine-Hematology and Oncology, Burrell College of Osteopathic Medicine (2021–2022)
- Co-chair of Internal Medicine, Internal Medicine, Memorial Medical Center, Las Cruces, NM (2021–2022)
- Physician, Memorial Medical Cancer Center, Las Cruces, NM (2017–2022)
- Member at Large, Memorial Medical Center, Las Cruces, NM (2020–2021)
Research Expertise:
- Co-director of research at Great Lakes Cancer Center: I am a co-director for clinical trials at Great Lakes Cancer Center. We have a multitude of clinical trials in treatment and supportive care. My interests lie in breast cancer, lung cancers and hematological malignancies.
- PRMC Member: Protocol Review Member for University of New Mexico
Journal Articles:
- Parikshit Padhi M.D., M.B.B.S; Naga Praneeth Raja M.D. (2023) Hereditary leiomyomatosis and renal cell cancer associated with metastatic rectal cancer. Current Problems in Cancer-case reports (Sep), 11 doi:https://doi.org/10.1016/j.cpccr.2023.100257
- Parikshit Padhi M.D. (2023) Acute Mania due to capecitabine and oxaliplatin in a patient with metastatic colon cancer. Current problems in cancer-case reports (Mar), 9: 100225. doi:https://doi.org/10.1016/j.cpccr.2023.100225
- Padhi P, Topalovski M. (2021) Benign Metastasizing Leiomyoma of the Uterus with Pulmonary and Bone Metastases. Case reports in obstetrics and gynecology (Jan), 2021: 5536675. doi:10.1155/2021/5536675
- Padhi P, El-Behery R. (2020) Extramedullary Solitary Plasmacytoma with Anaplastic Features of the Nasopharynx. Case reports in hematology (Jan), 2020: 8845546. doi:10.1155/2020/8845546
- Padhi P, Topalovski M, El Behery R, Cantu ES, Medavarapu R. (2018) A Rare Case of Chronic Myelogenous Leukemia Presenting as T-Cell Lymphoblastic Crisis. Case reports in oncological medicine (Jan), 2018: 7276128. doi:10.1155/2018/7276128
- Pasricha G, Padhi P, Daboul N, Monga DK. (2017) Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review. Clinical therapeutics (Nov), 39(11): 2146-2157.
- Padhi P, Narula A, Balog A, Christou A. (2016) Use of molecular studies for treatment of metastatic pleomorphic large cell pancreatic cancers-a novel strategy. Journal of gastrointestinal oncology (Apr), 7(2): E17-21. doi:10.3978/j.issn.2078-6891.2015.118
- Padhi P, Mackey C. (2013) Spine and scapular pain: an unusual presentation of colon adenocarcinoma. BMJ case reports (Jul), 2013. doi:10.1136/bcr-2013-010239
- Padhi P, Parihar GS, Stepp J, Kaplan R. (2013) Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia. BMJ case reports (May), 2013. doi:10.1136/bcr-2013-008860
- Singh S, Goyal V, Padhi P, Aoun E. (2013) Bacteroides fragilis endocarditis in a patient with Crohn's disease. BMJ case reports (Apr), 2013. doi:10.1136/bcr-2013-009248
Abstracts:
- Pritam Tayshetye, Parikshit Padhi, Rohit Rao, Tatyana Yurievna Sklyar, Abhishek Chilkulwar, Rickey Miller, Amy Tang, Shifeng Mao. (2018) Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors. Journal of Clinical Oncology, ASCO 2018. Chicago, Illinois (Jun)
- Parikshit Padhi, MD, Abhishek Chilkulwar, MD, Cyrus Khan, MD, Monank Patel, PharmD, BCOP, John Lister, MD, Xiaoqin Tang, PhD Director of Biostatistics. (2016) Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL). Blood, ASH. (Dec), (627)
Evaluative Studies and Case Reports:
- Parikshit Padhi M.D. Traci White PharmD Nesliha Cetin M.D. (2021) Successful Treatment of Nivolumab plus Ipilimumab--Mediated Pure Red-Cell Aplasia and Diabetes with Cyclosporine. Journal of Hematology Oncology Pharmacy (Oct), 11(5): 264-268.
Professional Memberships:
- American Society of Clinical Oncology (2017–present)
Presentations:
- "Reduced Intensity Conditioning (Fludarabine and Busulfan) for Allogeneic Hematopoietic Cell Transplantation in Patients with Severe Aplastic Anemia." ASBMT (2016)
- "Reduced Intensity Fludarabine and Intravenous Busulfan (FB2) for Allogeneic Hematopoietic Cell Transplantion(allo-HCT)" ASBMT (2016)
- "Adjuvant treatment for hormone positive (HR+) HER2 negative breast cancer" Grand Rounds Jan 2023
Service Activities:
- I am the co-director of clinical research at Great Lakes Cancer Center. We are involved in multiple pharmaceutical clinical trials for our cancer patients.; Co-director for research at Great Lakes Cancer Center (2023–present)
- I provide mentorship in the clinical practice of hematology and oncology for medical students who rotate through our cancer center.; Mentorship of students (2022–2023)